Dealmaking

Audax eyes add-ons to scale life science platform Resonant

Audax plans to target add-ons that will increase the convenience, accountability and speed of Resonant's distribution network.

Venture debt: Advanced deal sourcing strategies to maximize returns

In Part 14 of his series on venture debt, Zack Ellison from Applied Real Intelligence shares advanced concepts for sourcing high-return venture debt deals.

Insurance in vogue as JC Flowers makes Italian play; Kartesia supports Goetzpartners MBO; Winterberg portfolio company makes women’s health add-on

Consulbrokers is an insurance broker with headquarters in Milan.

Monroe’s Zia Uddin says Wendel investment will speed up growth in private credit; plus New Mountain’s next single-asset CV

An interview with Monroe Capital president Zia Uddin about why the Chicago mid-market lender sold a 75 percent stake to Paris PE firm Wendel Group; sources say New Mountain Capital is readying another single-asset continuation fund; a conversation with Rick Zall, chair of the healthcare transactions and regulatory practice at law firm King & Spalding, about the changing environment for healthcare deals.

King & Spalding's Rick Zall: Behavioral health, home-based care, digital therapeutics ripe for PE

KKR's acquisition of SunFireMatrix and Consello's purchase of EHE Health are among the deals that exemplify the new trends.

Zia Uddin: Wendel's $1bn investment in Monroe will accelerate lender's growth

Chicago-based mid-market lender Monroe Capital is selling a 75% stake in the company to Paris PE firm Wendel Group.

Ardian outlines Vista Vision consolidation plans; CVC joins KKR in Superstruct Entertainment; Private equity signs energy transition deals

Superstruct owns and operates over 80 music festivals across 10 countries in Europe and Australia.

BayPine recruits Bain Capital veteran Will Tetler as partner

Prior to BayPine, Tetler was a managing director at Bain Capital Special Situations, where he led the North America technology, media and telecom vertical.

Ardian eyes M&A to expand Vista Vision’s network in Italy and beyond

Ardian acquired Vista, a chain of ophthalmology clinics, in early October.

New Mountain eyes $2.5bn process to extend hold over Real Chemistry

GP-led deals represented about 46% of the $40bn-$45bn of secondaries volume in the third quarter, according to research from PJT Park Hill.